University of Ioannina
Η σημασία της λοίμωξης από τον ιό HPV στον καρκίνο του στοματοφάρυγγα και της στοματικής κοιλότητας σε ασθενείς της Βορειοδυτικής Ελλάδας
Abstract
dc:descriptionOral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) represent biologically and clinically distinct entities within head and neck cancers. High-risk human papillomavirus (HPV) infection is an established driver and favorable prognostic factor in OPSCC, but its role in OSCC remains less clear. The aim of this study is to determine the prevalence of HPV infection in OPSCC and OSCC in patients from Northwest Greece, and to evaluate its role in carcinogenesis as well as in the prognosis of these cancers. This is primarily a prospective observational study, supplemented by retrospective data collection, involving patients with OPSCC and OSCC from the ENT and Maxillofacial Surgery Clinics of the University General Hospital of Ioannina during the period 24/12/2016 - 17/5/2025. In addition to Immunohistochemistry for p16 overexpression, the HPV-DNA Microarray technique targeting 49 HPV types in a single assay, was utilized for molecular detection and genotyping of HPV.Of 171 suspected cases, 145 SCCs were analyzed (OPSCC 88; OSCC 57). HPV was more frequent in OPSCC than OSCC (51.1% vs 17.5%). In OSCC, HPV DNA positivity and p16 overexpression were each 17.5%, with p16(+)/HPV(+) in 14.0%; all HPV(+) OSCCs carried non-16 high-risk (HR) types. In OPSCC, HR infections predominated, HPV16 was the most common single HR genotype (n=11), yet the cumulative burden of non-16 HR types was greater (27 vs 11). All p16-positive OPSCCs were HPV DNA(+) (28.4%). Clinicopathologic comparisons showed no significant OSCC differences by HPV status (all p>0.05). In OPSCC, HPV(+) tumors presented with more advanced T and N categories (both p<0.001; enrichment of T4 and N2) and higher clinical stage (stage II–III; p<0.001), while other features (M category, differentiation, vascular/perineural invasion, local recurrence) were similar (all p>0.05).398Key endpoints included disease-free survival (DFS) and overall survival (OS). Survival analysis was performed using the Kaplan-Meier method and between-group differences were evaluated via the log-rank test. In OSCC, HPV status showed no statistically significant association with DFS or OS. Prognosis was primarily determined by clinicopathologic variables, specifically, primary tumor stage, regional lymph node involvement, clinical stage, and treatment modality (all p < 0.05 for OS). In contrast, in OPSCC, HPV positivity was a strong independent predictor of improved OS (mean OS: 44.3 vs. 33.6 months; p=0.015) and remained beneficial within subgroups stratified by age, nodal status, stage, and treatment. Annual incidence and mean survival trends mirrored these findings, with rising or stable rates of HPV(+) OPSCC and enhanced outcomes for this group.In summary, OPSCC in this region is characterized by a high HPV burden with a genotype landscape in which non-16 HR types collectively exceed HPV16, whereas HPV(+) OSCCs are exclusively non-16 HR. The use of a comprehensive 49-genotype microarray likely enhanced detection of these non-16 HR infections and underscores the value of broad genotyping panels in epidemiologic characterization and future prevention strategies. Furthermore, HPV status exerts a profound positive impact on survival in OPSCC but does not significantly affect prognosis in OSCC, where traditional tumor- and treatment-related factors remain paramount. These findings underscore the critical importance of molecular and immunological profiling for risk stratification and management, particularly in the oropharynx, and advocate for the broader inclusion of HPV status in staging and therapeutic decision-making for head and neck cancers.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Litsou, Mprikena-Eleni
- Λίτσου, Μπρικένα-Ελένη
Subjects
dc:subject × 22- Καρκίνος στοματοφάρυγγα
- Καρκίνος στοματικής κοιλότητας
- HPV λοίμωξη
- HPV ανίχνευση και τυποποίηση
- Ανοσοϊστοχημεία
- Τεχνολογία μικροσυστοιχιών
- Πρόγνωση
- Επιβίωση
- Oropharyngeal cancer
- Oral cavity cancer
- HPV infection
- HPV detection and genotyping
- Immunohistochemistry
- Microarrays technology
- Prognosis
- Survival
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ωτορινολαρυγγολογία
- Clinical Medicine
- Medical and Health Sciences
- Otorhinolaryngology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61928